期刊文献+

无功能垂体腺瘤术后复发相关因素分析 被引量:3

Analysis of the related factors of post-operative recurrence of nonfunctional pituitary adenoma
下载PDF
导出
摘要 目的研究无功能垂体腺瘤术后复发的相关因素。方法对113例无功能垂体腺瘤患者的临床资料、治疗方法及随访结果进行logistic回归分析。结果术后复发与腺瘤侵袭性、手术切除程度、术后辅助治疗相关且差异显著(P<0.05)。侵袭性腺瘤的术后复发风险高于非侵袭性腺瘤;手术未能全切、术后未行辅助治疗者术后复发风险也较高。根据标准回归系数,术后辅助治疗对降低无功能垂体腺瘤术后复发风险的作用最大,其次依次为手术全切、腺瘤非侵袭性。其他因素如年龄、性别、瘤体大小等因素与复发无明显相关性。结论无功能垂体腺瘤术后复发是多因素作用的结果,临床工作者应正确、全面地认识这些因素的作用以便采取多种治疗措施降低无功能垂体腺瘤的术后复发率。 Objective To study the related factors of post-operative recurrence of nonfunctional pituitary adenoma. Methods The clinical data, therapeutic methods and following-up outcome of 113 patients of nonfunctional pituitary adenoma were recorded and statistically analyzed with logistic regression model. Results Recurrence after surgery was related to the invasion of adenomas, the resection range and the adjunct therapy after surgery. All these factors showed significant difference (P 〈 0. 05). The recurrent risk of invasive adenoma was higher than that of non-invasive adenoma. The high risk of recurrence also presented in patients with non-total resection or patients without post-operative adjunct therapy. According to the standard regression coefficient, the factor of the adjunct therapy played the most important role in reducing the recurrence rate of nonfunctional pituitary adenoma. The factor of the total resection after surgery was secondary and the factor of the invasion of adenoma was least. Other factors such as age, sex and the size were unrelated to the recurrence of nonfunctional pituitary adenoma. Conclusion Many factors contribute to the post-operative recurrence of nonfunctional pituitary adenoma. Clinical surgeons should be acquainted with them correctly, so comprehensive therapy can be taken to reduce the recurrence of nonfunctional pituitary adenoma.
出处 《中华神经外科疾病研究杂志》 CAS 2006年第3期215-217,共3页 Chinese Journal of Neurosurgical Disease Research
关键词 无功能垂体腺瘤 手术 复发 LOGISTIC回归分析 Nonfunctional pituitary adenoma Surgery Recurrence Logistic regression
  • 相关文献

参考文献11

  • 1郑川玉,丁学华.侵袭性垂体腺瘤的临床诊断与治疗现状[J].国外医学(神经病学.神经外科学分册),2004,31(1):19-22. 被引量:4
  • 2赵曜,李士其.复发性垂体瘤病因探讨[J].中国临床神经科学,2002,10(1):93-95. 被引量:15
  • 3Shimon I,Melmed S.Management of pituitary tumors[J].Ann Intern Med,1998,129(6):472-483.
  • 4Tanaka Y,Hongo K,Tada T,et al.Growth pattern and rate in residual nonfunctioning pituitary adenomas:correlations among tumor volume doubling time,patient age,and MIB-1 index[J].J Neurosurg,2003,98(2):359-365.
  • 5Turner HE,Stratton IM,Byrne JV,et al.Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation-a follow-up study[J].Clin Endocrinol(Oxf),1999,51(3):281-284.
  • 6Kreutzer J,Fahlbusch R.Diagnosis and treatment of pituitary tumors[J].Curr Opin Neurol,2004,17(6):693-703.
  • 7王嵘.垂体腺瘤复发相关特性——高增殖和侵袭性[J].国外医学(神经病学.神经外科学分册),1998,25(5):242-245. 被引量:3
  • 8窦万臣,马超,王任直,任祖渊.复发性垂体腺瘤的诊断和治疗[J].中华神经外科杂志,2002,18(2):131-132. 被引量:16
  • 9Lissett CA,Shalet SM.Management of pituitary tumours:strategy for investigation and follow-up[J].Horm Res,2000,53(Suppl 3):65-70.
  • 10Gittoes NJ,Bates AS,Tse W,et al.Radiotherapy for non-function pituitary tumours[J].Clin Endocrinol,1998,48(3):331-337.

二级参考文献29

  • 1张建宁 杨树源.垂体腺瘤复发后的观察及相关因素分析[J].国外医学:神经病学.神经外科学分册,1998,25:306-308.
  • 2[1]Thapar K, Kovacs K, Sehelthauer BW, et al. Proliferative activity and invasiveness mnong pituitary adeenonas and carcinomas: analysis using the MIB-l antibody[J]. J Neurosurg, 1996, 38:99-107
  • 3[2]Kawamoto H, Daly MA, Mililan I, et al. Type IV collagenase activity and cavernous sinus invasion in the hunman pituitary adenoma [ J ]. Acta Neurochir, 1996, 138(4):390-340
  • 4[3]Yildiz F, Zorlu F, Erbas T, et al. Radiotherapy in the management of giant pituitary adenomas[J]. Radiother Oncol, 1999, 52:233-237
  • 5[4]Jho HD, Carraiu RL, Ko Y, et al. Endoscopic pituitary surgery: an early experience[J]. Surg Neurol, 1999, 47:213-222
  • 6[5]Basaria S, Turchin A, Krasner A. Apoplexy in recurrent pituitaryadenomas[J]. Postgrad Med J, 2001, 77:23-26
  • 7[6]Tan EU, Ho MS, Rjasoorya Cr. Metanororphosis of non-functioning pituitary adenonta to Cushing's disease[J]. Pituitary, 2000, 3:117-122
  • 8[7]Machiavelli GA, Yoshimoto T, Schiwa T. Expression of c-myc and binding site: estradial and progesterone in hunan pituitary tumor[J]. Neurol Res,1998, 20:709-712
  • 9[8]Shimom I, Pinget M, Kessler 1. Prolactinomas express human heparinbinding secretory transformation gene (hst) protein product: marker oftumor invasiveness[J]. Clin Endocrinol Oxf, 1998, 48:23
  • 10[9]Thapar K, Schirna W, Atahaan L, et al. p53 expression in pituitarryadenoma and carcinonms: correlation with invasiveness and tumor growthfraction[J]. Neurosurgery, 1996, 38:763-769

共引文献34

同被引文献30

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部